Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy- A Modeling Approach By The Brazilian Public Health Care System Perspective
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1944
https://www.valueinhealthjournal.com/article/S1098-3015(17)32278-7/fulltext
Title :
Cost-Effectiveness of Levetiracetam for Patients With Juvenile Myoclonic Epilepsy- A Modeling Approach By The Brazilian Public Health Care System Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32278-7&doi=10.1016/j.jval.2017.08.1944
First page :
A722
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1766